Literature DB >> 16840800

Galectin-1: a small protein with major functions.

Isabelle Camby1, Marie Le Mercier, Florence Lefranc, Robert Kiss.   

Abstract

Galectins are a family of carbohydrate-binding proteins with an affinity for beta-galactosides. Galectin-1 (Gal-1) is differentially expressed by various normal and pathological tissues and appears to be functionally polyvalent, with a wide range of biological activity. The intracellular and extracellular activity of Gal-1 has been described. Evidence points to Gal-1 and its ligands as one of the master regulators of such immune responses as T-cell homeostasis and survival, T-cell immune disorders, inflammation and allergies as well as host-pathogen interactions. Gal-1 expression or overexpression in tumors and/or the tissue surrounding them must be considered as a sign of the malignant tumor progression that is often related to the long-range dissemination of tumoral cells (metastasis), to their dissemination into the surrounding normal tissue, and to tumor immune-escape. Gal-1 in its oxidized form plays a number of important roles in the regeneration of the central nervous system after injury. The targeted overexpression (or delivery) of Gal-1 should be considered as a method of choice for the treatment of some kinds of inflammation-related diseases, neurodegenerative pathologies and muscular dystrophies. In contrast, the targeted inhibition of Gal-1 expression is what should be developed for therapeutic applications against cancer progression. Gal-1 is thus a promising molecular target for the development of new and original therapeutic tools.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16840800     DOI: 10.1093/glycob/cwl025

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  276 in total

Review 1.  Pancreatic ductal adenocarcinoma: a review of immunologic aspects.

Authors:  Megan B Wachsmann; Laurentiu M Pop; Ellen S Vitetta
Journal:  J Investig Med       Date:  2012-04       Impact factor: 2.895

2.  The thymus microenvironment in regulating thymocyte differentiation.

Authors:  Jacy Gameiro; Patrícia Nagib; Liana Verinaud
Journal:  Cell Adh Migr       Date:  2010-07-15       Impact factor: 3.405

3.  Galectins regulate the inflammatory response in airway epithelial cells exposed to microbial neuraminidase by modulating the expression of SOCS1 and RIG1.

Authors:  Mihai Nita-Lazar; Aditi Banerjee; Chiguang Feng; Gerardo R Vasta
Journal:  Mol Immunol       Date:  2015-09-06       Impact factor: 4.407

4.  Novel fluorescent glycan microarray strategy reveals ligands for galectins.

Authors:  Xuezheng Song; Baoyun Xia; Sean R Stowell; Yi Lasanajak; David F Smith; Richard D Cummings
Journal:  Chem Biol       Date:  2009-01-30

5.  Radiation-induced galectin-1 by endothelial cells: a promising molecular target for preferential drug delivery to the tumor vasculature.

Authors:  Meenakshi Upreti; Azemat Jamshidi-Parsian; Scott Apana; Marc Berridge; Daniel A Fologea; Nathan A Koonce; Ralph L Henry; Robert J Griffin
Journal:  J Mol Med (Berl)       Date:  2012-10-23       Impact factor: 4.599

6.  Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation.

Authors:  Neus Martínez-Bosch; Maite G Fernández-Barrena; Mireia Moreno; Elena Ortiz-Zapater; Jessica Munné-Collado; Mar Iglesias; Sabine André; Hans-Joachim Gabius; Rosa F Hwang; Françoise Poirier; Carolina Navas; Carmen Guerra; Martin E Fernández-Zapico; Pilar Navarro
Journal:  Cancer Res       Date:  2014-05-08       Impact factor: 12.701

7.  NMR and MD investigations of human galectin-1/oligosaccharide complexes.

Authors:  Christophe Meynier; Mikael Feracci; Marion Espeli; Florence Chaspoul; Philippe Gallice; Claudine Schiff; Françoise Guerlesquin; Philippe Roche
Journal:  Biophys J       Date:  2009-12-16       Impact factor: 4.033

Review 8.  Engineering better immunotherapies via RNA interference.

Authors:  Mouldy Sioud
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

9.  The involvement of CD146 and its novel ligand Galectin-1 in apoptotic regulation of endothelial cells.

Authors:  Nathalie Jouve; Nicolas Despoix; Marion Espeli; Laurent Gauthier; Sophie Cypowyj; Karim Fallague; Claudine Schiff; Françoise Dignat-George; Frédéric Vély; Aurélie S Leroyer
Journal:  J Biol Chem       Date:  2012-12-07       Impact factor: 5.157

10.  Dissociation of the carbohydrate-binding and splicing activities of galectin-1.

Authors:  Patricia G Voss; Richard M Gray; Seth W Dickey; Weizhong Wang; Jung W Park; Ken-Ichi Kasai; Jun Hirabayashi; Ronald J Patterson; John L Wang
Journal:  Arch Biochem Biophys       Date:  2008-07-16       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.